Zhaoyan Chen

973 total citations
50 papers, 564 citations indexed

About

Zhaoyan Chen is a scholar working on Geriatrics and Gerontology, Family Practice and Economics and Econometrics. According to data from OpenAlex, Zhaoyan Chen has authored 50 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Geriatrics and Gerontology, 13 papers in Family Practice and 10 papers in Economics and Econometrics. Recurrent topics in Zhaoyan Chen's work include Pharmaceutical Practices and Patient Outcomes (21 papers), Medication Adherence and Compliance (13 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Zhaoyan Chen is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (21 papers), Medication Adherence and Compliance (13 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Zhaoyan Chen collaborates with scholars based in China, Hong Kong and United States. Zhaoyan Chen's co-authors include Fangyuan Tian, Ting Xu, Qiyi Feng, Ruonan Yang, Xi Chen, Yachao Zeng, Jinhui Wu, Dan Zhou, Mengnan Zhao and Haixia Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Zhaoyan Chen

46 papers receiving 557 citations

Peers

Zhaoyan Chen
Olga Laosa Spain
Fangyuan Tian China
Andreea Farcaș Romania
Amir Sarayani Iran
Stephen Kogut United States
Marisa Battistella Canada
Ana Paula Martins Portugal
Anand Harugeri India
Mercedes Aza‐Pascual‐Salcedo Spain
Hyun Soon Sohn South Korea
Olga Laosa Spain
Zhaoyan Chen
Citations per year, relative to Zhaoyan Chen Zhaoyan Chen (= 1×) peers Olga Laosa

Countries citing papers authored by Zhaoyan Chen

Since Specialization
Citations

This map shows the geographic impact of Zhaoyan Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoyan Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoyan Chen more than expected).

Fields of papers citing papers by Zhaoyan Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoyan Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoyan Chen. The network helps show where Zhaoyan Chen may publish in the future.

Co-authorship network of co-authors of Zhaoyan Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoyan Chen. A scholar is included among the top collaborators of Zhaoyan Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoyan Chen. Zhaoyan Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Zhang, Ying, et al.. (2024). The prevalence and factors associated with potentially inappropriate medications in Chinese older outpatients with heart failure. BMC Geriatrics. 24(1). 1040–1040. 1 indexed citations
3.
Yu, Xiaoping, Zhaoyan Chen, Wei Bao, et al.. (2024). The neutrophil extracellular traps in neurological diseases: an update. Clinical & Experimental Immunology. 218(3). 264–274. 5 indexed citations
4.
Zhou, Dan, Zhaoyan Chen, & Fangyuan Tian. (2024). Corrigendum to ‘Deprescribing Interventions for Older Patients: A Systematic Review and Meta-Analysis’ [Journal of the American Medical Directors Association 24 (2023)1718-1725]. Journal of the American Medical Directors Association. 25(11). 105305–105305. 1 indexed citations
5.
Chen, Zhaoyan, et al.. (2024). Cost-effectiveness analysis of bevacizumab combined with lomustine in the treatment of progressive glioblastoma using a Markov model simulation analysis. Frontiers in Public Health. 12. 1410355–1410355. 3 indexed citations
6.
Chen, Zhaoyan & Fangyuan Tian. (2023). Evaluation of oral small molecule drugs for the treatment of COVID-19 patients: a systematic review and network meta-analysis. Annals of Medicine. 55(2). 2274511–2274511. 5 indexed citations
7.
Bao, Wei, Hao Wan, Xiaoping Yu, et al.. (2023). Model for predicting prognosis and immunotherapy based on CD+8 T cells infiltration in neuroblastoma. Journal of Cancer Research and Clinical Oncology. 149(12). 9839–9855. 1 indexed citations
8.
Chen, Zhaoyan, Qiyi Feng, Xiaoxing Wang, & Fangyuan Tian. (2023). Prophylactic use amphotericin B use in patients with hematologic disorders complicated by neutropenia: a systematic review and meta-analysis. Scientific Reports. 13(1). 14008–14008.
9.
Chen, Zhaoyan, et al.. (2023). The Measurement and Spatial-Temporal Distribution of the Development Level of China's Digital Economy. South Asian Journal of Social Studies and Economics. 19(3). 1–10. 1 indexed citations
10.
Chen, Zhaoyan, Ya Zeng, & Fangyuan Tian. (2022). Developing a third-degree burn model of rats using the Delphi method. Scientific Reports. 12(1). 13852–13852. 9 indexed citations
11.
Tian, Fangyuan, Ruonan Yang, Zhaoyan Chen, Xiaoxia Duan, & Ping Yuan. (2022). The prevalence and factors associated with potentially inappropriate medication use in Chinese older outpatients with cancer with multimorbidity. Journal of Geriatric Oncology. 13(5). 629–634. 7 indexed citations
12.
Tian, Fangyuan, Zhaoyan Chen, Rui Tang, Qiyi Feng, & Fengbo Wu. (2022). Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: An interrupted time series analysis, 2016–2021. Frontiers in Pharmacology. 13. 992394–992394. 2 indexed citations
13.
Tian, Fangyuan, Zhaoyan Chen, Xi Chen, & Mengnan Zhao. (2022). Increasing Trends of Polypharmacy and Potentially Inappropriate Medication Use in Older Lung Cancer Patients in China: A Repeated Cross-Sectional Study. Frontiers in Pharmacology. 13. 935764–935764. 6 indexed citations
14.
Zhang, Ying, Zhaoyan Chen, & Fangyuan Tian. (2022). Potentially inappropriate medications in older Chinese outpatients based on the Beers criteria and Chinese criteria. Frontiers in Pharmacology. 13. 991087–991087. 6 indexed citations
15.
16.
17.
Pei, Supeng, et al.. (2020). Fe, N-doped carbon spheres prepared by electrospinning method as high efficiency oxygen reduction catalyst. RSC Advances. 10(2). 779–783. 7 indexed citations
18.
Wu, Bin, et al.. (2019). Development of a trigger tool for the detection of adverse drug events in Chinese geriatric inpatients using the Delphi method. International Journal of Clinical Pharmacy. 41(5). 1174–1183. 12 indexed citations
19.
Xu, Yangyang, et al.. (2014). Smad4 suppresses the progression of renal cell carcinoma via the activation of forkhead box protein H1. Molecular Medicine Reports. 11(4). 2717–2722. 7 indexed citations
20.
Chen, Zhaoyan, et al.. (2007). EEG Study on Transcutaneous Electrical Acupoint Stimulation as a Fatigue Countermeasure.. Hangtian yixue yu yixue gongcheng. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Olga Laosa Breakdown of academic impact, for papers by Fangyuan Tian Breakdown of academic impact, for papers by Andreea Farcaș Breakdown of academic impact, for papers by Amir Sarayani Breakdown of academic impact, for papers by Stephen Kogut Breakdown of academic impact, for papers by Marisa Battistella Breakdown of academic impact, for papers by Ana Paula Martins Breakdown of academic impact, for papers by Anand Harugeri Breakdown of academic impact, for papers by Mercedes Aza‐Pascual‐Salcedo Breakdown of academic impact, for papers by Hyun Soon Sohn
Rankless by CCL
2026